From Yahoo Finance: 2025-04-02 09:02:00

Hims & Hers Health, Inc. (HIMS) shares were trading at $31.05 on April 1st, with a trailing and forward P/E of 58.58 and 52.08 respectively. Despite competition, Hims differentiates itself through a superior user experience and expanding suite of personalized treatments. The company remains undervalued, trading at just over 5x sales.

Hims represents a compelling long-term investment opportunity, with a direct-to-consumer healthcare model resetting consumer expectations. The company’s ability to aggregate proprietary data at scale strengthens its competitive position. Hims has the potential to become a dominant force in digital healthcare as it continues to scale personalized treatments and expand into new healthcare verticals.

Hims & Hers Health, Inc. (HIMS) is not among the 30 most popular stocks among hedge funds. While HIMS carries risk as an investment, some AI stocks may offer greater promise for higher returns within a shorter timeframe. Investors seeking a promising AI stock trading at less than 5 times its earnings can explore alternatives to HIMS.



Read more at Yahoo Finance: Hims & Hers Health, Inc. (HIMS): A Bull Case Theory